Skip to main content

Table 5 Comparison of IBC expression of ER, PR, and HER2 between BRCA1- and BRCA2-associated tumors

From: DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3

 

BRCA1

BRCA2

Wilcoxon rank sum P value

ER intensity

  

<0.001

 0

38

8

 

 1

1

0

 

 2

4

7

 

 3

2

11

 

PR intensity

  

<0.001

 0

40

10

 

 1

0

1

 

 2

1

5

 

 3

4

10

 

HER2 intensity

  

0.56

 0

33

19

 

 1

13

7

 

 2

3

2

 

 3

0

2

Â